IDEAS home Printed from https://ideas.repec.org/a/wly/hlthec/v31y2022i7p1513-1521.html
   My bibliography  Save this article

Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees

Author

Listed:
  • Shyam Raman
  • Ashley C. Bradford

Abstract

The potential substitution of cannabis for prescription medication has attracted a substantial amount of attention within the context of medical cannabis laws (MCLs). However, much less is known about the association between recreational cannabis laws (RCLs) and prescription drug use. With recent evidence supporting substitution of cannabis for prescription drugs following MCLs, it is reasonable to ask what effect RCLs may have on those outcomes. We use quarterly data for all Medicaid prescriptions from 2011 to 2019 to investigate the effect of state‐level RCLs on prescription drug utilization. We estimate this effect with a series of two‐way fixed effects event study models. We find significant reductions in the volume of prescriptions within the drug classes that align with the medical indications for pain, depression, anxiety, sleep, psychosis, and seizures. Our results suggest substitution away from prescription drugs and potential cost savings for state Medicaid programs.

Suggested Citation

  • Shyam Raman & Ashley C. Bradford, 2022. "Recreational cannabis legalizations associated with reductions in prescription drug utilization among Medicaid enrollees," Health Economics, John Wiley & Sons, Ltd., vol. 31(7), pages 1513-1521, July.
    • Handle: RePEc:wly:hlthec:v:31:y:2022:i:7:p:1513-1521
    DOI: 10.1002/hec.4519
    as

    Download full text from publisher

    File URL: https://doi.org/10.1002/hec.4519
    Download Restriction: no
    File URL: https://libkey.io/10.1002/hec.4519?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Alex Hollingsworth & Coady Wing & Ashley C. Bradford, 2022. "Comparative Effects of Recreational and Medical Marijuana Laws on Drug Use among Adults and Adolescents," Journal of Law and Economics, University of Chicago Press, vol. 65(3), pages 515-554.
    2. Powell, David & Pacula, Rosalie Liccardo & Jacobson, Mireille, 2018. "Do medical marijuana laws reduce addictions and deaths related to pain killers?," Journal of Health Economics, Elsevier, vol. 58(C), pages 29-42.
    3. Chelsea L. Shover & Corey S. Davis & Sanford C. Gordon & Keith Humphreys, 2019. "Association between medical cannabis laws and opioid overdose mortality has reversed over time," Proceedings of the National Academy of Sciences, Proceedings of the National Academy of Sciences, vol. 116(26), pages 12624-12626, June.
    4. Jiebing Wen & Hefei Wen & J. S. Butler & Jeffery C. Talbert, 2021. "The impact of medical and recreational marijuana laws on opioid prescribing in employer‐sponsored health insurance," Health Economics, John Wiley & Sons, Ltd., vol. 30(5), pages 989-1000, May.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Rahi Abouk & Keshar M. Ghimire & Johanna Catherine Maclean & David Powell, 2023. "Pain Management and Work Capacity: Evidence From Workers’ Compensation and Marijuana Legalization," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 42(3), pages 737-770, June.
    2. Shyam Raman & Johanna Catherine Maclean & W. David Bradford & Coleman Drake, 2023. "Recreational cannabis and opioid distribution," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 747-754, April.
    3. Ahmed El Fatmaoui, 2024. "From high school to higher education: Is recreational marijuana a consumption amenity for US college students?," Economic Inquiry, Western Economic Association International, vol. 62(3), pages 1024-1045, July.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Coleman Drake & Jiebing Wen & Jesse Hinde & Hefei Wen, 2021. "Recreational cannabis laws and opioid‐related emergency department visit rates," Health Economics, John Wiley & Sons, Ltd., vol. 30(10), pages 2595-2605, September.
    2. Sabia, Joseph J. & Dave, Dhaval & Alotaibi, Fawaz & Rees, Daniel I., 2024. "The effects of recreational marijuana laws on drug use and crime," Journal of Public Economics, Elsevier, vol. 234(C).
    3. Anderson, D. Mark & Rees, Daniel I., 2021. "The Public Health Effects of Legalizing Marijuana," IZA Discussion Papers 14292, Institute of Labor Economics (IZA).
    4. Mathur, Neil K. & Ruhm, Christopher J., 2023. "Marijuana legalization and opioid deaths," Journal of Health Economics, Elsevier, vol. 88(C).
    5. Borbely, Daniel & Lenhart, Otto & Norris, Jonathan & Romiti, Agnese, 2022. "Marijuana Legalization and Mental Health," IZA Discussion Papers 15729, Institute of Labor Economics (IZA).
    6. Marinello, Samantha & Powell, Lisa M., 2023. "The impact of recreational cannabis markets on motor vehicle accident, suicide, and opioid overdose fatalities," Social Science & Medicine, Elsevier, vol. 320(C).
    7. Thanh Lu, 2021. "Marijuana legalization and household spending on food and alcohol," Health Economics, John Wiley & Sons, Ltd., vol. 30(7), pages 1684-1696, July.
    8. Junxing Chay & Seonghoon Kim, 2022. "Heterogeneous health effects of medical marijuana legalization: Evidence from young adults in the United States," Health Economics, John Wiley & Sons, Ltd., vol. 31(2), pages 269-283, February.
    9. Hollingsworth, Alex & Wing, Coady, 2020. "Tactics for design and inference in synthetic control studies: An applied example using high-dimensional data," SocArXiv fc9xt, Center for Open Science.
    10. Grant W. Neeley & Lilliard E. Richardson Jr., 2022. "Marijuana Policy Bundles in the American States Over Time and Their Impact on the Use of Marijuana and Other Drugs," Evaluation Review, , vol. 46(2), pages 165-199, April.
    11. Shyam Raman & Johanna Catherine Maclean & W. David Bradford & Coleman Drake, 2023. "Recreational cannabis and opioid distribution," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 747-754, April.
    12. Cheng, Stephanie F. & De Franco, Gus & Lin, Pengkai, 2023. "Marijuana liberalization and public finance: A capital market perspective on the passage of medical use laws," Journal of Accounting and Economics, Elsevier, vol. 75(1).
    13. Antonios M. Koumpias & Charles Courtemanche & Jordan W. Jones & Daniela Zapata, 2024. "Revisiting the connection between state Medicaid expansions and adult mortality," Southern Economic Journal, John Wiley & Sons, vol. 91(1), pages 187-212, July.
    14. Mir M. Ali & Chandler McClellan & Ryan Mutter & Daniel I. Rees, 2023. "Recreational marijuana laws and the misuse of prescription opioids: Evidence from National Survey on Drug Use and Health microdata," Health Economics, John Wiley & Sons, Ltd., vol. 32(2), pages 277-301, February.
    15. Davide Fortin, 2024. "Legalizing cannabis in Colorado: Displacement or market expansion?," French Stata Users' Group Meetings 2024 03, Stata Users Group.
    16. Smart, Rosanna & Doremus, Jacqueline, 2023. "The kids aren’t alright: The effects of medical marijuana market size on adolescents," Journal of Health Economics, Elsevier, vol. 87(C).
    17. Christopher J. Ruhm, 2019. "Shackling the Identification Police?," Southern Economic Journal, John Wiley & Sons, vol. 85(4), pages 1016-1026, April.
    18. d'Este, Rocco, 2022. "Scientific Advancements in Illegal Drugs Production and Institutional Responses: New Psychoactive Substances, Self-Harm, and Violence inside Prisons," IZA Discussion Papers 15248, Institute of Labor Economics (IZA).
    19. Kalbfuss, Jörg & Odermatt, Reto & Stutzer, Alois, 2024. "Medical marijuana laws and mental health in the United States," Health Economics, Policy and Law, Cambridge University Press, vol. 19(3), pages 307-322, July.
    20. David Powell & Rosalie Liccardo Pacula, 2021. "The Evolving Consequences of OxyContin Reformulation on Drug Overdoses," American Journal of Health Economics, University of Chicago Press, vol. 7(1), pages 41-67.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:hlthec:v:31:y:2022:i:7:p:1513-1521. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www3.interscience.wiley.com/cgi-bin/jhome/5749 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.